Andreessen Horowitz
Listed as “Abridge”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Abridge
Abridge develops generative AI documentation for clinical conversations.
- Industry
- Healthcare
- Tracked VC backers
- 5
RiseFinder summary
Abridge uses generative AI for documentation of clinical conversations in healthcare settings, with a focus on healthcare understanding.
- Company website ↗ · Checked
Tracking coverage and points
Tracking coverage
Some public sources are being tracked. Coverage varies by milestone.
- Momentum +1 · Tracking
- Comparable public measurements available. Points depend on your pick date.Last comparable reading:
- Fundraising +2 · Awaiting data
- No verified dated source evidence recorded.
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Tracking
- Official news source checked. A missing event does not establish inactivity.News checked:
Coverage describes public evidence. Points require a qualifying milestone after your pick.
Publicly documented VC backing
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
Andreessen Horowitz
Listed as “Abridge”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Bessemer Venture Partners
Listed as “Abridge”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Khosla Ventures
Listed as “Abridge”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Lightspeed Venture Partners
Listed as “Abridge”
- First observed:
- 29 Oct 2026
- Investment announced:
- Date not recorded
Spark Capital
Listed as “Abridge”
- First observed:
- 31 Oct 2026
- Investment announced:
- Date not recorded
Dated public activity
No dated funding or investment events are recorded yet. Initial portfolio listings establish the starting baseline and earn no points.